Lars Henrik Jensen

PhD. Associate Professor, Consultant, MD

20062020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Lars Henrik Jensen is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 21 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

  • Open Access
    File
  • 2 Downloads (Pure)

    Landmark survival analysis and impact of anatomic origin in prospective clinical trials of biliary tract cancer

    McNamara, M. G., Lopes, A., Wasan, H., Malka, D., Goldstein, D., Shannon, J., Okusaka, T., Knox, J. J., Wagner, A. D., André, T., Cunningham, D., Moehler, M., Jensen, L. H., Koeberle, D., Bekaii-Saab, T., Bridgewater, J. & Valle, J. W., 21. May 2020, In : Journal of Hepatology.

    Research output: Contribution to journalJournal articleResearchpeer-review

  • Long-Term Patient-Reported Outcomes After High-Dose Chemoradiation Therapy for Nonsurgical Management of Distal Rectal Cancer

    Dizdarevic, E., Frøstrup Hansen, T., Pløen, J., Henrik Jensen, L., Lindebjerg, J., Rafaelsen, S., Jakobsen, A. & Appelt, A., 1. Mar 2020, In : International Journal of Radiation Oncology Biology Physics. 106, 3, p. 556-563

    Research output: Contribution to journalJournal articleResearchpeer-review

  • Phase II study of gemcitabine, oxaliplatin and capecitabine in patients with KRAS exon 2 mutated biliary tract cancers

    Jensen, L. H., Andersen, R. F., Byriel, L., Fernebro, E., Jakobsen, A., Lindebjerg, J., Nottelmann, L., Ploen, J. & Hansen, T. F., Mar 2020, In : Acta oncologica (Stockholm, Sweden). 59, 3, p. 298-301

    Research output: Contribution to journalJournal articleResearchpeer-review

  • Activities

    • 2 Talks and presentations in private or public companies
    • 1 Other

    Diagnose, behandling og overlevelse efter galdekræft i Danmark

    Linda Kærlev (Participant), Lars Henrik Jensen (Participant), Bente Mertz Nørgård (Participant)
    2017

    Activity: Other activitiesOther

    Gene expression of MLH1 related to microsatellite instability, immuno-histochemistry, and promoter hypermethylation in colorectal cancer

    Lars Henrik Jensen (Speaker)
    2007

    Activity: Talks and presentationsTalks and presentations in private or public companies

    Patients' preference for oral Navelbine in NSCLC

    Lars Henrik Jensen (Speaker)
    2007

    Activity: Talks and presentationsTalks and presentations in private or public companies

    Prizes

    Bevilling

    Linda Kærlev (Recipient), Bente Mertz Nørgård (Recipient) & Lars Henrik Jensen (Recipient), 2017

    Prize: Prizes, scholarships, distinctions